Abstract
The most critical feature of the cellular response to DNA damage is the ability of the cell to pause and repair the damage so that detrimental mutations will not be passed along to future generations of cells. The cell cycle of mammalian cells is equipped with checkpoints that can prevent cell cycle progression. Cells can either be arrested before replication of the DNA when the cells have a 2 N amount of DNA or after replication and prior to cell mitosis when the cells have a 4 N amount of DNA. Flow cytometry is a standard technique that is used to ‘sort’ cells based on their DNA content. It uses the principles of light scattering, light excitation, and emission of fluorochrome molecules to generate data about individual cells. The cells are fixed and permeabilized so that the DNA can be stained with a fluorescent dye. Cells that have a 2 N amount of DNA can be separated from cells with a 4 N amount of DNA. Using this technique, changes in the profile of the G1, S, and G2/M phases of the cell cycle are readily seen after DNA damage.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hartwell, L. H., and Weinert, T. A. (1989) Checkpoints: controls that ensure the order of cell cycle events, Science 246, 629–634.
Paulovich, A. G., Toczyski, D. P., and Hartwell, L. H. (1997) When checkpoints fail, Cell 88, 315–321.
Finlay, C. A., Hinds, P. W., and Levine, A. J. (1989) The p53 proto-oncogene can act as a suppressor of transformation, Cell 57, 1083–1093.
Kern, S. E., Kinzler, K. W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C., and Vogelstein, B. (1991) Identification of p53 as a sequence-specific DNA-binding protein, Science 252, 1708–1711.
Pietenpol, J. A., Tokino, T., Thiagalingam, S., el-Deiry, W. S., Kinzler, K. W., and Vogelstein, B. (1994) Sequence-specific transcriptional activation is essential for growth suppression by p53, Proc Natl Acad Sci USA 91, 1998–2002.
Burns, T. F., and El-Deiry, W. S. (1999) The p53 pathway and apoptosis, J Cell Physiol 181, 231–239.
Bargonetti, J., and Manfredi, J. J. (2002) Multiple roles of the tumor suppressor p53, Curr Opin Oncol 14, 86–91.
el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression, Cell 75, 817–825.
Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases, Cell 75, 805–816.
Waldman, T., Kinzler, K. W., and Vogelstein, B. (1995) p21 is necessary for the p53-mediated G1 arrest in human cancer cells, Cancer Res 55, 5187–5190.
Waga, S., Hannon, G. J., Beach, D., and Stillman, B. (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA, Nature 369, 574–578.
Agarwal, M. L., Agarwal, A., Taylor, W. R., and Stark, G. R. (1995) p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts, Proc Natl Acad Sci USA 92, 8493–8497.
Flatt, P. M., Tang, L. J., Scatena, C. D., Szak, S. T., and Pietenpol, J. A. (2000) p53 regulation of G(2) checkpoint is retinoblastoma protein dependent, Mol Cell Biol 20, 4210–4223.
Matsuoka, S., Huang, M., and Elledge, S. J. (1998) Linkage of ATM to cell cycle regulation by the Chk2 protein kinase, Science 282, 1893–1897.
Taylor, W. R., DePrimo, S. E., Agarwal, A., Agarwal, M. L., Schonthal, A. H., Katula, K. S., and Stark, G. R. (1999) Mechanisms of G2 arrest in response to overexpression of p53, Mol Biol Cell 10, 3607–3622.
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., and Vogelstein, B. (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage, Science 282, 1497–1501.
Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W., and Vogelstein, B. (1999) 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage, Nature 401, 616–620.
Kastan, M. B., Zhan, Q., el-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr. (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia, Cell 71, 587–597.
Malkin, D. (1993) p53 and the Li-Fraumeni syndrome, Cancer Genet Cytogenet 66, 83–92.
Acknowledgments
The authors would like to thank Dana Lukin for contributing figures from his PhD dissertation. The authors are supported by grants from the National Cancer Institute (P01 CA080058, R01 CA125741, and R01 CA086001).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Resnick-Silverman, L., Manfredi, J.J. (2011). Analyzing p53 Regulated DNA Damage Checkpoints by Flow Cytometry. In: Li, W. (eds) Cell Cycle Checkpoints. Methods in Molecular Biology, vol 782. Humana Press. https://doi.org/10.1007/978-1-61779-273-1_14
Download citation
DOI: https://doi.org/10.1007/978-1-61779-273-1_14
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-272-4
Online ISBN: 978-1-61779-273-1
eBook Packages: Springer Protocols